Stopping GLP-1 weight loss drugs like Ozempic and Wegovy often leads to rapid weight regain and returning health risks.

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Explore the benefits and side effects of popular weight loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. Learn how ...

At a high level these drugs mimic glucagon-like peptide-1, or GLP-1, a hormone our bodies naturally produce in the gut. When ...

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: Ozempic may help improve testosterone levels in people ...

Powerful new weight-loss medications are in the works to treat obesity. Doctors explain why more options are needed and the ...

Not just a buzzword, "Ozempic face" represents a real concern for some. A bariatric surgeon shares the causes, solutions and expert advice everyone should know Ozempic, a medication initially ...

Last month, the Trump administration announced major plans to slash prices of GLP-1s, including Ozempic, Wegovy, Zepbound, and Mounjaro. The agreement will lower prices of these medications from ...

DEC 15 (Reuters) - A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly alleging patients lost some or all of their eyesight while ...